Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Humacyte, Inc.

UNLOXCYT (cosibelimab-ipdl) is indicated for the treatment of adults with metastatic cutaneous squamous cell carcinoma (“cSCC”) or locally advanced cSCC who are not candidates for curative surgery or ...

NDAQ:WBD) Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Warner Bros. Discovery, Inc. (WBD) Shareholders ...

NDAQ:CELH) Class Action Filed Against Celsius Holdings, Inc. (CELH) Seeking Recovery for Investors - Contact Levi & Korsinsky ...

NDAQ:CDMO) The Schall Law Firm Urges Stockholder Participation In An Inquiry Into Avid Bioservices Inc For Possible Securities Fraud ...

NDAQ:FLNC) FLNC Investors Have Opportunity to Join Fluence Energy, Inc. Securities Fraud Investigation with the Schall Law Firm ...

NDAQ:MTCH) Levi & Korsinsky Notifies Match Group, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - MTCH ...

December 12, 2024) - Kovo+ Holdings Inc. (formerly Kovo HealthTech Corporation) (TSXV: KOVO) ("Kovo" or the "Company") is pleased to announce a best efforts private placement (the "Offering") ...

NDAQ:BCYC) Bicycle Therapeutics Announces Data Updates Across Zelenectide Pevedotin Program and Development Strategy Leveraging NECTIN4 Gene Amplification ...

OTCPK:MBBC) Marathon Bancorp, Inc. Announces Adoption of Plan of Conversion and Reorganization to Undertake Second Step Conversion ...

NYSE:IIPR) The Schall Law Firm Invites Shareholder Contributions To An Inquiry Into Innovative Industrial Properties, Inc. For Securities Law Violations ...

NYSE:ELF) The Schall Law Firm Encourages Shareholder Participation In An Inquiry Into e.l.f. Beauty Inc For Securities Law Violations ...